Several young scientists were honored recently with the 2005 Kathryn Grupe Awards for Excellence in Research on Alzheimer's Disease and Related Disorders.
This annual award, granted by the local chapter of the
Alzheimer's Association, recognizes noteworthy research by postdoctoral fellows, graduate students and undergraduate students.
Elizabeth Edgerly, PhD, program director of the Alzheimer's association, presented the awards at the Bay Area Alzheimer's Disease Research Symposium at the Gladstone Institutes. Awards went to Luke Esposito, PhD, and Erik Roberson, MD, PhD, both with the
Gladstone Institute of Neurological Disease (GIND), and Adriane Mayda of UC Davis. Honorable mentions went to Daniel Jimenez of Stanford University and GIND's Gayathri Ramaswamy, PhD.
|
| Pictured in the back row, from left, are Lennart Mucke, director of the Gladstone Institute of Neurological Disease (GIND), and winners Luke Esposito and Erik Roberson. Pictured in the front row, from left, are GIND's Gayathri Ramaswamy, Adriane Mayda of UC Davis, Elizabeth Edgerly, Alzheimer's Association, and Daniel Jimenez of Stanford University. |
The Gladstone Institute of Neurological Disease and the local chapter of the Alzheimer's Association co-hosted the symposium, involving some of the world's leading Alzheimer's researchers discussing promising avenues of research being conducted in the greater Bay Area. Speakers at the May 26 event included investigators from Gladstone, UCSF, the Buck Institute, UC Davis and Stanford University.
"Gladstone brought Alzheimer's disease research to the Mission Bay campus with its move here last October," explained Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease. "We were thrilled to co-host this exciting event. It illustrated how current research can contribute to the development of better treatments, and, judged by the lively discussions, it certainly helped foster further collaboration."
Highlights of the day's activities included Mucke discussing neuronal deficits caused by amyloid proteins and Gladstone Institutes President Robert Mahley presenting findings on apoE4 and Alzheimer's disease. Bruce Miller, MD, Director, UCSF
Memory & Aging Center and Alzheimer's Disease Research Center, covered new clinical approaches to dementia. Other speakers included Dale Bredesen, MD, of the Buck Institute for Age Research, Jerome Yesavage, MD, of Stanford University's Alzheimer's Disease Center, Li Gan, PhD, of the Gladstone Institute of Neurological Disease, and Charles DeCarli, MD, of UC Davis' Alzheimer's Disease Center, among many others. A half-hour GIND tour followed the program and luncheon.
The Alzheimer's Association is the nation's largest private funder of Alzheimer research. Since its founding 25 years ago, it has, through its peer-review process, awarded $165 million to nearly 1,400 projects, including research in the greater Bay Area.
The Gladstone Institute of Neurological Disease is one of three research institutes of The
J. David Gladstone Institutes, a private, nonprofit biomedical research institution affiliated with UCSF.
Source: John Watson
